NBIO .065 - bullish writeup at biopharmajournal...
By Gavins Felicity -September 29, 2020
Nascent Biotech Inc. (OTCMKTS:NBIO) is a clinical stage biopharmaceutical company with a number of potential drivers and catalysts in play. Today, we take a look at recent analysis and company-specific factors, as well as the macro context, to provide a detailed examination of the stock and its prospects.